Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04395937 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Sep 1, 2023 to Sep 1, 2028v4 Show 6 more changesShow less
    • Primary endpoints: 24 to 1
    • Interventions: exercises (Other) to Aerobic exercise training (Other), Respiratory physiotherapy (Other)
    • Eligibility criteria revised
    • Secondary endpoints expanded, about 50 words
    • Study description expanded, about 16 words
    • Study title expanded, about 2 words
  2. Study arms: 2 to 3v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoints: 23 to 24
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Liege
40 trials monitored
See 1 trial at risk
Asthma
956 trials monitored
See 34 trials at risk
The effects of regular exercise on asthma control has not yet been well demonstrated. The aim of this study is to investigate the impact of submaximal aerobic training on exercise tolerance (VO2max - primary outcome) and a set of secondary outcomes: quality of life, asthma symptoms control, bronchial and systemic inflammatory markers, lung function, bronchial hyperresponsiveness, anxiety and depression and body composition in patients with persistant asthma.
Trial Details
NCT Number NCT04395937
Lead Sponsor University of Liege
Conditions
(from sponsor)		 Chronic Asthma
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov